Skip to main content

Table 1 Epidemiological characteristics of pulmonary tuberculosis patients notified in Shanghai, China, in the first half of each of 2017 and 2018*

From: Effect of the Xpert MTB/RIF on the detection of pulmonary tuberculosis cases and rifampicin resistance in Shanghai, China

Characteristics

Total

n (%)

(n = 6047)

PTB patients of 2017

n (%)

(n = 2938)

PTB patients of 2018

n (%)

(n = 3109)

p-value

Sex

   

0.912

 Female

1910 (31.6)

930 (31.7)

980 (31.5)

 

 Male

4137 (68.4)

2008 (68.3)

2129 (68.5)

 

Age

   

0.198

 15–29

1887 (31.2)

904 (30.8)

983 (31.6)

 

 30–44

1190 (19.7)

578 (19.7)

612 (19.7)

 

 45–59

1171 (19.4)

601 (20.5)

570 (18.3)

 

  > =60

1799 (29.8)

855 (29.1)

944 (30.4)

 

Hospital

   

0.928

 County-level

1901 (31.4)

922 (31.4)

979 (31.5)

 

 Referral

4146 (68.6)

2016 (68.6)

2130 (68.5)

 

Local resident

   

0.829

 No

2781 (46.0)

1347 (45.8)

1434 (46.1)

 

 Yes

3266 (54.0)

1591 (54.2)

1675 (53.9)

 

TB case

   

0.208

 New

5608 (92.7)

2712 (92.3)

2896 (93.1)

 

 Previously treated

439 (7.3)

226 (7.7)

213 (6.9)

 

Bacteriological confirmation

   

< 0.001

 Yes

3290 (54.4)

1461 (49.7)

1829 (58.8)

 

DST coverage

   

< 0.001

 Yes

2573 (42.6)

1066 (36.3)

1507 (48.5)

 

RR-TB detection

   

0.004

 Yes

156 (2.6)

58 (2.0)

98 (3.2)

 
  1. PTB pulmonary tuberculosis
  2. Xpert Xpert MTB/RIF
  3. MTB Mycobacteria of tuberculosis
  4. RIF Rifampicin
  5. RR-TB Rifampicin-resistant tuberculosis
  6. DST Drug susceptibility test
  7. *Xpert was implemented in 2018